Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Gong

Showing results (91-100 of 317) with videos related to

Pageof 32
Sort By:
Frontiers in Cell and Developmental Biology|August 16, 2021
MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYLGehao Liang, Yun Ling, Qun Lin, et al.
The AAPS Journal|June 26, 2019
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung CancerMohammad Jafarnejad, Chang Gong, Edward Gabrielson, et al.
Journal of Inorganic Biochemistry|September 12, 2008
Synthesis and structural characterization of the mono- and diphosphine-containing diiron propanedithiolate complexes related to [FeFe]-hydrogenases. Biomimetic H2 evolution catalyzed by (mu-PDT)Fe2(CO)4[(Ph2P)2N(n-Pr)]Li-Cheng Song, Chang-Gong Li, Jian-Hua Ge, et al.
American Journal of Obstetrics and Gynecology|April 20, 2010
Comprehensive miRNA profiling of surgically staged endometrial cancerDavid E Cohn, Muller Fabbri, Nicola Valeri, et al.
Inorganic Chemistry|February 22, 2021
Strategy for Achieving Long-Wavelength Near-Infrared Luminescence of Diimineplatinum(II) ComplexesMeng-Meng Su, Jia-Jia Kang, Shu-Qin Liu, et al.
Medcomm|July 13, 2026
Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple-Negative Breast Cancer: Real-World Outcomes From a Retrospective Cohort StudyYudong Li, Jinna Lin, Mengdi Zhu, et al.
Scientific Reports|August 4, 2019
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint BlockadeOleg Milberg, Chang Gong, Mohammad Jafarnejad, et al.
Journal of Cancer|July 15, 2024
EGR1 Promotes Erastin-induced Ferroptosis Through Activating Nrf2-HMOX1 Signaling Pathway in Breast Cancer CellsZhirong Lin, Zifei Liu, Zhilong Pan, et al.
Breast (Edinburgh, Scotland)|April 14, 2024
Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapyHaizhu Chen, Xiujuan Gui, Ziwei Zhou, et al.
Nucleic Acids Research|July 20, 2010
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentialsEsmerina Tili, Jean-Jacques Michaille, Chang-Gong Liu, et al.
Pageof 32

Showing results (91-100 of 317) with videos related to

Sort By:
Pageof 32
Frontiers in Cell and Developmental Biology|August 16, 2021
MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYLGehao Liang, Yun Ling, Qun Lin, et al.
The AAPS Journal|June 26, 2019
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung CancerMohammad Jafarnejad, Chang Gong, Edward Gabrielson, et al.
Journal of Inorganic Biochemistry|September 12, 2008
Synthesis and structural characterization of the mono- and diphosphine-containing diiron propanedithiolate complexes related to [FeFe]-hydrogenases. Biomimetic H2 evolution catalyzed by (mu-PDT)Fe2(CO)4[(Ph2P)2N(n-Pr)]Li-Cheng Song, Chang-Gong Li, Jian-Hua Ge, et al.
American Journal of Obstetrics and Gynecology|April 20, 2010
Comprehensive miRNA profiling of surgically staged endometrial cancerDavid E Cohn, Muller Fabbri, Nicola Valeri, et al.
Inorganic Chemistry|February 22, 2021
Strategy for Achieving Long-Wavelength Near-Infrared Luminescence of Diimineplatinum(II) ComplexesMeng-Meng Su, Jia-Jia Kang, Shu-Qin Liu, et al.
Medcomm|July 13, 2026
Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple-Negative Breast Cancer: Real-World Outcomes From a Retrospective Cohort StudyYudong Li, Jinna Lin, Mengdi Zhu, et al.
Scientific Reports|August 4, 2019
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint BlockadeOleg Milberg, Chang Gong, Mohammad Jafarnejad, et al.
Journal of Cancer|July 15, 2024
EGR1 Promotes Erastin-induced Ferroptosis Through Activating Nrf2-HMOX1 Signaling Pathway in Breast Cancer CellsZhirong Lin, Zifei Liu, Zhilong Pan, et al.
Breast (Edinburgh, Scotland)|April 14, 2024
Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapyHaizhu Chen, Xiujuan Gui, Ziwei Zhou, et al.
Nucleic Acids Research|July 20, 2010
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentialsEsmerina Tili, Jean-Jacques Michaille, Chang-Gong Liu, et al.
Pageof 32